Public signalCompany raiseAuto-indexed · Unverified
Grannus Therapeutics, Inc. raised $800K
Grannus Therapeutics, Inc.· INDIANAPOLIS, US· Biotechnology· Filed Jan 12, 2024
Grannus Therapeutics, Inc. reported raising capital. Based in INDIANAPOLIS, INDIANA, US. First sale reported 2023-11-17. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$800,000
Confidence90%
Raised
$800,000
Investors
9
Incorporated
2020
Jurisdiction
UNITED STATES
On the record
- Location
- INDIANAPOLIS, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $800,000
- Target amount
- $800,000
- Filing date
- Jan 12, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- UNITED STATES
- Year incorporated
- 2020
- Industry group
- Biotechnology
- Number of investors
- 9
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $800,000
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 800,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 12, 2024. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$100K – $1MCompany Raise
Are you associated with Grannus Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record